Newswire Study Links Pulmonary Hypertension to Cognitive Decline November 3, 2026 A study by University of Pittsburgh and UPMC researcher-clinicians has uncovered a connection between pulmonary…
Newswire Karyopharm to Auction Itself Amid Bankruptcy November 3, 2026 Karyopharm, a company facing significant debt issues, is set to be the lead bidder in…
Newswire FDA Approves Generic HIV Prevention Shot by Dr. Reddy’s Laboratories November 3, 2026 After months of anticipation, the Food and Drug Administration gave tentative approval to Dr. Reddy’s…
Newswire Sourcing Strategies for API Supply Chain Resilience November 3, 2026 The pharmaceutical supply chain, which moves drugs from raw materials to patients, begins with Active…
Newswire Technology Transfer Essential for Manufacturing Readiness November 3, 2026 Successful technology transfer involves more than just completing documentation; it requires ensuring that the receiving…
Newswire 10x Genomics Launches Sentira for Single-Cell Analysis November 3, 2026 10x Genomics has launched Sentira Single Cell, a cloud-based analysis tool powered by Anthropic’s Claude…
Newswire Navigating Complexity in Biologics Development November 3, 2026 The biologics industry is facing increased complexity as pipelines expand beyond monoclonal antibodies to include…
Newswire Keytruda Biosimilars Face Market Challenges November 3, 2026 A patent cliff is approaching for Merck’s flagship blockbuster Keytruda, which could open the door…
Newswire FDA Delays PDUFA Action on Agios’ Mitapivat sNDA for SCD November 3, 2026 The FDA has delayed a decision on Agios Pharmaceuticals’ supplemental New Drug Application (sNDA) seeking…
Newswire AstraZeneca Restructures, Alnylam Faces Challenges, Regeneron Reports Success November 3, 2026 AstraZeneca is set to redeploy resources as part of a new restructuring program aimed at…